NIOX PANEL FOR USE WITH THE NIOX MINO AIRWAY INFLAMMATION MONITOR— 510(k) K123683

Substantially Equivalent

Aerocrine AB

FDA 510(k) clearance K123683 for NIOX PANEL FOR USE WITH THE NIOX MINO AIRWAY INFLAMMATION MONITOR, Substantially Equivalent on 2012-12-27. Applicant: Aerocrine AB.

Clearance details

Applicant: Aerocrine AB
Product code: Code MXA
Advisory panel: Clinical Toxicology
Date received: 2012-11-30
Decision date: 2012-12-27
Decision: Substantially Equivalent
Clearance type: Special
Location: Solna, SE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.